| Name | Number of Reports | Reference(s) | Data Source | |
|---|---|---|---|---|
| 1 | Sumatriptan | FAERS: 268 | US FAERS | |
| 2 | Baclofen | FAERS: 78 Canada Vigilance: 1 | Canada Vigilance US FAERS | |
| 3 | treprostinil | FAERS: 12 | US FAERS | |
| 4 | carbidopa, levodopa drug combination | FAERS: 4 | US FAERS | |
| 5 | LCZ 696 | FAERS: 3 | US FAERS | |
| 6 | Iloprost | FAERS: 2 | US FAERS | |
| 7 | 4-hydroxybutyric acid | FAERS: 1 | US FAERS | |
| 8 | Cannabidiol | FAERS: 1 | US FAERS | |
| 9 | Clonidine | FAERS: 1 | US FAERS | |
| 10 | Dronedarone | FAERS: 1 | US FAERS | |
| 11 | Epoprostenol | FAERS: 1 | US FAERS | |
| 12 | Metformin | FAERS: 1 | US FAERS | |
| 13 | Morphine | FAERS: 1 | US FAERS | |
| 14 | Thalidomide | FAERS: 1 | US FAERS | |
| 15 | apremilast | FAERS: 1 | US FAERS | |
| 16 | riociguat | FAERS: 1 | US FAERS |
Page last updated at 2020-05-25 10:01:57 (Asia/Shanghai) | You are visitor No. 120241
Copyright © 2019-2020 Laboratory of Molecular Modeling and Design, Shanghai Key Laboratory of New Drug Design, School of Pharmacy, East China University of Science and Technology. All rights reserved.